Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05849935 · ClinicalTrials.gov registry record
abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003
A clinical trial, sponsored by Abionic.
- Completed
- Registry status
- 61
- Enrollment target
NCT05849935 is a clinical trial that has completed, run by Abionic. The registered enrollment target is 61 participants.
The verdict
NCT05849935 has completed, sponsored by Abionic.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
This is a monocentric, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.
Interventions
- DIAGNOSTIC_TEST abioSCOPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2023-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05849935
The ClinicalTrials.gov registry entry for NCT05849935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abionic, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which abioSCOPE is the first listed.
NCT05849935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05849935 about?
NCT05849935 is a clinical study titled "abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003". This is a monocentric, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.
What is the current status of trial NCT05849935?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2023-07-17. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05849935?
The interventions under investigation include: abioSCOPE (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05849935?
This trial is sponsored by Abionic, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.